Skip to main content


Table 2 Types of inhaled corticosteroids used by the COPD population. Reference patients did not use ICS

From:  Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study

Variable COPD patients with lung function data (N = 6623)a
Types of ICS, n (%)
 Budesonide 2317 (71.5)
 Fluticasone propionate 236 (7.3)
 Budesonide/fluticasone propionateb 655 (20.2)
 Other 30 (0.9)
  1. aNo ICS n = 3385; bIncludes patients that switched from budesonide to fluticasone propionate and fluticasone propionate to budesonide during the study period, as well as a few patients that were using both budesonide and fluticasone propionate at the same time
  2. COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids